In regards to CD45+CD3+CD4+ cells, we observed repression of CD4 and CD45(= PTPRC) in patients with increased FGF21 expression (Figure 6B), whereas CD3 is up‐regulated in all MASLD patients (see Figure S10A). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.